Bearish MACD for Salix
- On 2:42 pm EDT, Friday October 30, 2009
Salix Pharmaceuticals Ltd.’s (NasdaqGS: SLXP - News) MACD indicator has moved into bearish territory with a reading of -0.1085. The Zacks #4 Rank (“Sell) stock fell nearly 1% to $16.20 in afternoon trade. The Zacks Consensus Estimate on the company’s full-year earnings is currently pegged at a loss of 92 cents per share, which has worsened by 2 cents over the past 2 months.
SALIX PHARMACEUTICALS LTD (SLXP): Free Stock Analysis Report
|
Related Headlines
- SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits - EDGAR Online
- Salix Pharmaceuticals to Present at Piper Jaffray Conference - Business Wire
- Salix Pharmaceuticals completes stock offering - AP
- SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibi - EDGAR Online
- Salix Pharmaceuticals, Ltd. Completes Sale of 6.325 Million Shares of Common Stock - Business Wire
Related Blog Headlines
- Salix Beats on Xifaxan Strength - Zacks.com
- Bearish MACD for Salix - Zacks.com
- Salix: Approval of Rifaximin Would Help Drive Long-Term Growth - at Seeking Alpha
- Rifaximin on track for New Indications - Zacks.com
- Metozolv ODT Launch on Track - Zacks.com
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today.
-
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale. -
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month.
More From Provider
- Read the analyst report on SLXP Zacks.com
Tech Ticker Recent Posts
- Housing Bottom? "Not Even Close," Barry Ritholtz Says - Aaron Task
- A Bad Economy Could Spell Good News on Wall Street for Years to Come - Peter Gorenstein
- The FDIC Is $8.2 Billion in the Hole - John Carney
Add Alert © 2009 Zacks.com. All rights reserved.